Retrospective analysis of glioblastoma multiforme (GBM) patients treated initially with BCNU compared to temozolomide (TMZ) with concomitant radiation therapy

被引：0
|
作者：
Vinjamuri, M. [1 ]
Adumala, R. [1 ]
Altaha, R. [1 ]
Hobbs, J. [1 ]
Crowell, E. [1 ]
机构：
[1] West Virginia Univ, Morgantown, WV USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2071
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Bevacizumab, temozolomide, and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly-diagnosed glioblastoma multiforme (GBM).
    Vredenburgh, J. J.
    Desjardins, A.
    Reardon, D. A.
    Peters, K.
    Kirkpatrick, J.
    Coan, A. D.
    Bailey, L.
    Janney, D.
    Lu, C.
    Friedman, H. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] BEVACIZUMAB (BV) IN COMBINATION TO TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM): A PHASE 2 TRIAL
    Desjardins, Annick
    Reardon, David A.
    Peters, Katherine B.
    Herndon, James
    Kirkpatrick, John
    Gururangan, Sridharan
    Sampson, John H.
    Friedman, Allan H.
    Friedman, Henry
    Vredenburgh, James J.
    NEURO-ONCOLOGY, 2009, 11 (05) : 634 - 634
  • [33] The addition of bevacizumab to temozolomide and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly diagnosed glioblastoma multiforme (GBM).
    Friedman, Henry S.
    Desjardins, Annick
    Peters, Katherine B.
    Reardon, David A.
    Kirkpatrick, John
    Herndon, James Emmett
    Coan, April D.
    Bailey, Leighann
    Sampson, John Howard
    Friedman, Allan H.
    Vredenburgh, James J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] Concurrent Temozolomide (TMZ) Improves Survival, but Increases Toxicity, in Elderly Patients with Glioblastoma Multiforme (GBM) Treated with Standard (STD) or Abbreviated (ABR) Radiotherapy (RT)
    Barker, C. A.
    Chang, M.
    Chou, J. F.
    Zhang, Z.
    Gutin, P. H.
    Beal, K.
    Abrey, L. E.
    Iwamoto, F. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S167 - S167
  • [35] Hypofractionated radiation therapy with temozolomide versus standard chemoradiation in patients with glioblastoma multiforme (GBM): A prospective, single institution experience
    Rayan, Amal
    Abdel-Kareem, Samya
    Hasan, Huda
    Zahran, Asmaa M.
    Gamal, Doaa A.
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2020, 25 (06) : 890 - 898
  • [36] NABTT 0306: A randomized phase II trial of EMD 121974 in conjunction with concomitant and adjuvant temozolomide with radiation therapy in patients with newly diagnosed glioblastoma multiforme (GBM)
    Nabors, L. B.
    Mikkelsen, T.
    Batchelor, T.
    Lesser, G.
    Rosenfeld, M.
    Ye, X.
    Piantadosi, S.
    Olson, J.
    Brem, S.
    Grossman, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [37] Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme
    Fadul, Camilo E.
    Fisher, Jan L.
    Gui, Jiang
    Hampton, Thomas H.
    Cote, Anik L.
    Ernstoff, Marc S.
    NEURO-ONCOLOGY, 2011, 13 (04) : 393 - 400
  • [38] THE EFFECT OF TIMING OF RADIOTHERAPY (RT) IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) RECEIVING TEMOZOLOMIDE (TMZ): AN ANALYSIS BASED ON THE UCSF EXPERIENCE
    Han, S. J.
    Rutledge, W. C.
    Molinaro, A. M.
    Chang, S.
    Clarke, J. L.
    Prados, M. D.
    Berger, M. S.
    Butowski, N. A.
    NEURO-ONCOLOGY, 2014, 16
  • [39] THE EFFECT OF DELAYING RADIOTHERAPY (RT) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) RECEIVING TEMOZOLOMIDE (TMZ): A SECONDARY ANALYSIS BASED ON THE UCSF EXPERIENCE
    Butowski, Nicholas A.
    Polley, Mei-Yin C.
    Lamborn, Kathleen L.
    Chang, Susan
    Prados, Michael
    Clarke, Jennifer L.
    Huang, Kim
    Sneed, Patricia
    NEURO-ONCOLOGY, 2009, 11 (05) : 665 - 665
  • [40] Mgmt expression correlates with response rate and survival in patients with inoperable glioblastoma (GBM) treated with neoadjuvant temozolomide (TMZ)
    Barrie, M.
    Eudes, N.
    Boucard, C.
    Metellus, P.
    Fuentes, S.
    Honoré, S.
    Dufour, H.
    Figarella-Branger, D.
    Chinot, O.
    NEURO-ONCOLOGY, 2006, 8 (04) : 352 - 352
12345